Quarterly report pursuant to Section 13 or 15(d)

Organization and Business (Details Narrative)

v3.21.2
Organization and Business (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Jan. 28, 2021
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
OrganizationAndBusinessLineItems [Line Items]                  
Cash and Cash Equivalents, Period Increase (Decrease)       $ 38,308,505          
Payments to Acquire Marketable Securities       80,902,119 $ (0)        
Net loss   $ 7,383,978 $ 383,258,002 83,642,921 389,093,946        
Net Cash Used in Operating Activities       8,972,775 2,331,260        
Accumulated deficit   553,200,246   553,200,246     $ 469,557,324    
Stockholders' Equity Attributable to Parent   171,621,715 63,218,056 171,621,715 63,218,056 $ 175,681,817 119,196,677 $ 4,387,868 $ 9,086,702
Current assets   152,521,636   152,521,636     108,566,089    
Cash and cash equivalents   58,372,335 $ 54,382,775 58,372,335 54,382,775   100,456,324   $ 305,121
Current liabilities   15,507,100   15,507,100     7,178,906    
Working capital   $ 137,014,536   137,014,536     $ 101,387,183    
Proceeds from sale of stock       $ 57,264,656 $ 5,819,319        
Letter Agreements [Member]                  
OrganizationAndBusinessLineItems [Line Items]                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 39,740,500                
Warrant exercise price $ 1.55                
Proceeds from sale of stock $ 61,600,000                
Payments of Stock Issuance Costs $ 4,300,000                
Exercising Holders [Member]                  
OrganizationAndBusinessLineItems [Line Items]                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 39,740,500                
Warrant exercise price $ 2.37